Careers | Find us | Contact us
2025-09-04T14:01:06+01:004 September 2025|
In this eighth part of our innovator blog series, we spoke to Dr Jolynne Mokaya, Public Health Lead at the Wellcome Sanger Institute. With an entrepreneurial and ingenious spirit, Jolynne is helping to build a community of practice of cholera experts that will facilitate and progress research by leveraging regional expertise across several continents.
2025-05-06T12:41:28+01:006 May 2025|
We spoke to Dr Trevor Lawley, Senior Group Leader at the Wellcome Sanger Institute who works in the Parasites and Microbes Programme. Trevor’s is the story of turning basic, fundamental research into innovative science with potential to treat a broad range of human diseases.
2025-01-16T14:21:41+00:001 December 2024|
Based originally upon the research of the human microbiome carried out at the Wellcome Sanger Institute, Microbiotica was spun out as a microbiome therapeutics company in 2016. Today, Microbiotica is advancing steadily towards introducing transformational microbiome-based therapeutics and biomarkers in areas of high medical need, with first clinical trials – underpinned by a landmark £50m investment during 2022 – starting soon.
2024-08-07T11:55:13+01:002 August 2024|
In 2024, COSMIC – the world’s largest and most comprehensive resource on genetic mutations in cancer – celebrates two exciting milestones: COSMIC reaches its 20th anniversary and releases its 100th version of the database.
2024-07-05T10:06:46+01:003 July 2024|
The HipSci cell lines, now searchable in a newer, user-friendly platform, are a resource used worldwide by researchers. They can be used for a wide variety of research applications, including large-scale experiments that require multiple cell lines created in a standardised manner.
2024-07-05T10:06:23+01:0011 June 2024|
The fourth edition of Sanger’s Startup School closed with 30 participants from the Wellcome Sanger Institute and EMBL-EBI having gained the confidence to look at science with a different, entrepreneurial perspective.
2024-07-05T10:09:00+01:006 March 2024|
Meet Valentina Migliori, a researcher working to make lab science more relevant to clinical research.
2024-07-05T10:09:44+01:0015 February 2024|
We spoke to Jyoti Nangalia, a researcher at the forefront of innovation in blood cancers. She is combining her clinical and academic expertise to bring better diagnosis tools for patients and clinicians.
2024-07-05T10:40:12+01:006 February 2024|
Three vaccine targets discovered by the Wellcome Sanger Institute focus on targeting animal trypanosomiasis in an effort to find a cure for a disease that causes billions in economic losses in one of the poorest regions on earth. These losses fall heavily on small holders, who are often heavily dependent on livestock for their livelihood.
Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244
Wellcome Genome Campus,
Hinxton, Cambridgeshire, CB10 1SA. UK
+44 (0)1223 834244
